{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:06:13Z","timestamp":1772481973388,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40744-024-00663-4","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:01:39Z","timestamp":1714046499000},"page":"773-794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevating the Standard of Care for Patients with Axial Spondyloarthritis: \u2018Calls to Action\u2019 from Rheumacensus, a Multistakeholder Pan-European Initiative"],"prefix":"10.1007","volume":"11","author":[{"given":"Andri","family":"Phoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8560-9514","authenticated-orcid":false,"given":"Bart J. F.","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-5328","authenticated-orcid":false,"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-4944","authenticated-orcid":false,"given":"Cristina","family":"Fern\u00e1ndez-Carballido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlev","family":"Parow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-9362","authenticated-orcid":false,"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"issue":"2","key":"663_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40744-017-0066-2","volume":"4","author":"M Garrido-Cumbrera","year":"2017","unstructured":"Garrido-Cumbrera M, Hillman O, Mahapatra R, et al. Improving the management of psoriatic arthritis and axial spondyloarthritis: roundtable discussions with healthcare professionals and patients. Rheumatol Ther. 2017;4(2):219\u201331.","journal-title":"Rheumatol Ther"},{"issue":"5","key":"663_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11926-019-0819-8","volume":"21","author":"M Garrido-Cumbrera","year":"2019","unstructured":"Garrido-Cumbrera M, Poddudnyy D, Gossec L, et al. The European map of axial spondyloarthritis: capturing the patient perspective-an analysis of 2846 patients across 13 countries. Curr Rheumatol Rep. 2019;21(5):19.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"663_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12016-017-8637-0","volume":"55","author":"E Lubrano","year":"2018","unstructured":"Lubrano E, De Socia A, Perrotta FM. Unmet needs in axial spondyloarthritis. Clin Rev Allergy Immunol. 2018;55(3):332\u20139.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"663_CR4","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s40744-021-00375-z","volume":"8","author":"FM Perrotta","year":"2021","unstructured":"Perrotta FM, Scriffigano S, Lubrano E. MRI assessment of extra-axial findings at pelvic sites in a group of axial\u2013SpA patients. Rheumatol Ther. 2021;8(4):1897\u2013904.","journal-title":"Rheumatol Ther"},{"key":"663_CR5","doi-asserted-by":"crossref","unstructured":"Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ , Goodson NJ. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology (Oxford). 2020;59(Supp4):iv47\u201357.","DOI":"10.1093\/rheumatology\/keaa246"},{"issue":"7","key":"663_CR6","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s10067-022-06100-7","volume":"41","author":"CA Hay","year":"2022","unstructured":"Hay CA, Packham J, Ryan S, Mallen CD, Chatzixenitidis A, Prior JA. Diagnostic delay in axial spondyloarthritis: a systematic review. Clin Rheumatol. 2022;41(7):1939\u201350.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"663_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/acr2.11365","volume":"4","author":"WB Nowell","year":"2022","unstructured":"Nowell WB, Gavigan K, Hunter T, et al. Treatment satisfaction and decision-making from the patient perspective in axial spondyloarthritis: real-world data from a descriptive cross-sectional survey study from the ArthritisPower Registry. ACR Open Rheumatol. 2022;4(1):85\u201394.","journal-title":"ACR Open Rheumatol"},{"key":"663_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/rheumatology\/keab369","volume":"61","author":"M Garrido-Cumbrera","year":"2022","unstructured":"Garrido-Cumbrera M, Navarro-Comp\u00e1n V, Bundy C, et al. Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis. Rheumatol. 2022;61:705\u201312.","journal-title":"Rheumatol"},{"issue":"9","key":"663_CR9","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/rheumatology\/kez090","volume":"58","author":"I Redeker","year":"2019","unstructured":"Redeker I, Callhoff J, Hoffmann F, et al. Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. Rheumatol. 2019;58(9):1634\u20138.","journal-title":"Rheumatol"},{"issue":"11","key":"663_CR10","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1007\/s10067-022-06228-6","volume":"41","author":"H Marzo-Ortega","year":"2022","unstructured":"Marzo-Ortega H, Navarro-Comp\u00e1n V, Akar S, Kiltz U, Clark Z, Nikiphorou E. The impact of gender and sex on diagnosis, treatment outcomes and health-related quality of life in patients with axial spondyloarthritis. Clin Rheumatol. 2022;41(11):3573\u201381.","journal-title":"Clin Rheumatol"},{"key":"663_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40744-020-00194-8","volume":"7","author":"E Yi","year":"2020","unstructured":"Yi E, Ahuja A, Rajput T, George AT, Park Y. Clinical, economic, and humanistic burden associated with delayed diagnosis of axial spondyloarthritis: a systematic review. Rheumatol Ther. 2020;7:65\u201387.","journal-title":"Rheumatol Ther"},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/CEOR.S144209","volume":"10","author":"FS Mennini","year":"2018","unstructured":"Mennini FS, Viti R, Marcellusi A, Sciattella P, Viapiana O, Rossini M. Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy. Clinicoecon Outcomes Res. 2018;10:45\u201351.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"1","key":"663_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19\u201334.","journal-title":"Ann Rheum Dis"},{"key":"663_CR14","first-page":"1","volume":"12","author":"T Gudu","year":"2022","unstructured":"Gudu T, Jadon DR. Multidisciplinary working in the management of axial and peripheral spondyloarthritis. Ther Adv Musculoskel Dis. 2022;12:1\u20134.","journal-title":"Ther Adv Musculoskel Dis"},{"key":"663_CR15","doi-asserted-by":"crossref","unstructured":"van der Veen S, Evans N, Huisman M, Welch Saleeby P, Widdershoven G. Toward a paradigm shift in healthcare: using the International Classification of Functioning, Disability and Health (ICF) and the capability approach (CA) jointly in theory and practice. Disabil Rehabil. 2023;45(14):2382\u201389.","DOI":"10.1080\/09638288.2022.2089737"},{"key":"663_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/1472-6963-12-157","volume":"12","author":"M McAllister","year":"2012","unstructured":"McAllister M, Dunn G, Payne K, Davies L, Todd C. Patient empowerment: the need to consider it as a measurable patient-reported outcome for chronic conditions. BMC Health Serv Res. 2012;12:157.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"663_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.reuma.2022.02.008","volume":"19","author":"C Fern\u00e1ndez-Carballido","year":"2023","unstructured":"Fern\u00e1ndez-Carballido C, Almod\u00f3var R, Ca\u00f1ete JD, et al. Resources and strategies for the optimal care of patients with axial spondyloarthritis: the CREA project. Reumatol Clin (Engl Ed). 2023;19(2):82\u20139.","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"663_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.reuma.2020.01.003","volume":"17","author":"C Fernandez-Carballido","year":"2021","unstructured":"Fernandez-Carballido C, Collantes-Est\u00e9vez E, Gratac\u00f3s J, et al. Remission in axial spondyloarthritis: developing a consensus definition. Reumatol Clin (Engl Ed). 2021;17:380\u20137.","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"663_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40259-020-00464-5","volume":"35","author":"T Raine","year":"2021","unstructured":"Raine T, Gkini MA, Irving PM, et al. Maintaining clinical freedom whilst achieving value in biologics prescribing: an integrated cross-speciality consensus of UK dermatologists, rheumatologists and gastroenterologists. BioDrugs. 2021;35:187\u201399.","journal-title":"BioDrugs"},{"key":"663_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/annrheumdis-2019-216034","volume":"79","author":"U Klitz","year":"2020","unstructured":"Klitz U, et al. Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. Ann Rheum Dis. 2020;79:193\u2013201.","journal-title":"Ann Rheum Dis"},{"key":"663_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.semarthrit.2020.05.005","volume":"50","author":"GC Wright","year":"2020","unstructured":"Wright GC, Kaine J, Deodhar A. Understanding the differences between men and women with axial spondyloarthritis. Semin Arthritis Rheum. 2020;50:687\u201394.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00663-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-024-00663-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00663-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:31:48Z","timestamp":1716391908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-024-00663-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s40744-024-00663-4","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Stakeholder leads (namely, Andri Phoka, Bart J.F. van den Bemt and Xenofon Baraliakos) received an honorarium for their participation in the initial workshop and they and the other axSpA CC members (Ennio Lubrano, Inderjit Singh, Cristina Fern\u00e1ndez-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe) received an honorarium from UCB for their time to complete the Delphi e-consultations and to attend the axSpA CC meeting or provide their input offline. UCB Pharma reviewed the manuscript to ensure scientific and medical clarity and accuracy only. Bart J.F. van den Bemt received honorarium for lectures\/presentations from Lilly and support for attending meetings from AbbVie, Lilly and UCB. Cristina Fern\u00e1ndez-Carballido received honoraria for lectures\/presentations from AbbVie, Galapagos, Lilly, Novartis, Pfizer and UCB; consulting fees from AbbVie, Lilly, Novartis and UCB and support for attending meetings from AbbVie, Galapagos, Janssen, Lilly, Novartis, Roche and UCB. Detlev Parow received honoraria for advisory boards from Boehringer-Ingelheim, Hexal and UCB. Ennio Lubrano received honoraria for advisory boards and conference fees from AbbVie, Lilly, Novartis and UCB. Laura Harrington is an employee of Ogilvy Health. Xenefon Baraliakos received consultancy, research funding and honoraria from AbbVie, Amgen, Celltrion, Chugai, Lilly, Galapagos, Janssen, MSD, Novartis, Pfizer, Roche, Sandoz and UCB. National Axial Spondyloarthritis Society (on behalf of Dale Webb) received grant funding from AbbVie, Biogen, Lilly, Janssen, Novartis and UCB. Andri Phoka, Inderjit Singh and Fabienne Lacombe have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"There was no need to collect any type of patient data. Hence, the approval of an ethics committee was not required. Consent was obtained from all axSpA CC members as they were contracted by UCB Pharma to take part in this programme.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}